Hearscape
← Organizations
Company

Edison Pharmaceuticals Inc.

Company-level hearing-loss landscape profile across checked programs, evidence quality, modalities, indications, and open data checks.

All ProgramsTherapeuticsDevices
Open filtered programs
Programs
1
linked to organization
Strong Evidence
0
0 status confirmed
Details Checked
1
0 open data checks
Company / Institution Links
1 / 0
industry vs non-industry records
Competitive Density
3
Pipeline Velocity
0
Completion Signal
0

Programs by Stage

Phase 21

Trial / Program Status

Completed1

Modality Mix

Small Molecule1

Indication Coverage

Hearing Loss1
Noise-Induced Hearing Loss1
Sensorineural Hearing Loss1

Program Types

Therapeutic1

Population Tags

adult1
healthy-volunteer1
noise-induced1
repurposed-drug1

Strong-Evidence Records

0 records
No strong-evidence records are linked to this organization yet.

Checked Records With Caveats

1 checked · 0 open checks
EPI-743 by Edison Pharmaceuticals for noise-induced hearing loss
Details checked
Small MoleculePhase 2Completed

Oral redox-active small molecule/ubiquinone analog evaluated for protection against temporary noise-induced hearing loss, with study keywords indicating oxidative-stress biology.

Data checks: historical-completed-program, no-public-results-confirmed